New Drugs from Marine Organisms in Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Current approved drugs may only ameliorate symptoms in a restricted number of patients and for a restricted period of time. Currently, there is a translational research challenge into identifying the new effective drugs and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Patrizia, Kisialiou, Aliaksei, Lamonaca, Palma, Moroni, Rossana, Prinzi, Giulia, Fini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728502/
https://www.ncbi.nlm.nih.gov/pubmed/26712769
http://dx.doi.org/10.3390/md14010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728502/
https://www.ncbi.nlm.nih.gov/pubmed/26712769
http://dx.doi.org/10.3390/md14010005

Ejemplares similares